UK Markets closed

JNJ Jan 2021 210.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.1500+0.0200 (+15.38%)
As of 2:37PM EDT. Market open.
Full screen
Loading interactive chart…
  • Are Consumers and Investors Protected Against COVID-19 Vaccine Risks?
    Motley Fool

    Are Consumers and Investors Protected Against COVID-19 Vaccine Risks?

    Over the past several months, investors have gotten a few reminders that experimental vaccines can pose risks to trial participants. In turn, unexpected side effects and delays in the clinical trial process can punish stock prices. AstraZeneca's (NYSE: AZN) coronavirus vaccine trial is still on hold in the U.S. after a clinical trial participant experienced rare, severe, and potentially permanent side effects.

  • 5 Great Stocks You Can Buy and Hold Forever
    Motley Fool

    5 Great Stocks You Can Buy and Hold Forever

    Each of these companies has serious potential to bring profits to investors, especially those with long time horizons.

  • AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same
    Reuters

    AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same

    The news signaled progress against the novel coronavirus that has infected more than 41 million globally, including 8 million Americans and comes 10 days before a U.S. presidential election that may hinge on plans https://www.reuters.com/article/us-usa-election/biden-warns-on-coronavirus-surge-trump-heads-to-florida-in-campaign-sprint-idUSKBN2781A4 to fight the pandemic. AstraZeneca, one of the leading vaccine developers, paused its U.S. trial on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial. J&J paused its large, late-stage trial last week after a study participant became ill.